Skip to main content
. Author manuscript; available in PMC: 2012 Jul 23.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008305. doi: 10.1002/14651858.CD008305.pub2

Appendix 18. Sensitivity analysis taking into account risk of bias (‘incomplete outcome data’).

Outcome Sensitivity analysis on incomplete outcome
data
Result
1.1.4 TC Exclude studies biased on incomplete outcome
data (Ding 1999; Li 2006; Qi 2004)
MD 0.17 (95% CI −0.29 to 0.62)
I2 = 91%
1.1.3 TC Exclude study biased on incomplete outcome
data (Xu 2000)
MD −0.03 (95% CI −0.22 to 0.15)
I2 = 0%
1.1.5 TC Exclude study biased on incomplete outcome
data (Feng 2006)
MD −0.94 (95% CI −1.22 to −0.66)
I2 = not applicable
1.1.7 TC Exclude study biased on incomplete outcome
data (Wang 2006)
MD −0.02 (95% CI −0.44 to 0.40)
I2 = not applicable
1.2.4 TG Exclude studies biased on incomplete outcome
data (Li 2006; Qi 2004)
MD −0.08 (95% CI −0.21 to 0.05)
I2 = 62%
1.2.3 TG Exclude study biased on incomplete outcome
data (Xu 2000)
MD −0.06 (95% CI −0.17 to 0.06)
I2 = 93%
1.2.5 TG Exclude study biased on incomplete outcome
data (Feng 2006)
MD 0.08 (95% CI −0.19 to 0.35)
I2 = not applicable
1.3.4 HDL-C Exclude studies biased on incomplete outcome
data (Ding 1999; Qi 2004)
MD 0.08 (95% CI −0.03 to 0.19)
I2 = 86%
1.3.3 HDL-C Exclude study biased on incomplete outcome
data (Xu 2000)
MD 0.03 (95% CI −0.09 to 0.15)
I2 = 57%
1.3.5 HDL-C Exclude study biased on incomplete outcome
data (Feng 2006)
MD 0.24 (95% CI 0.01 to 0.47)
I2 = not applicable
1.4.4 LDL-C Exclude studies biased on incomplete outcome
data (Ding 1999; Li 2006; Qi 2004)
MD 0.04 (95% CI −0.28 to 0.35)
I2 = 88%
1.4.3 LDL-C Exclude study biased on incomplete outcome
data (Xu 2000)
MD −0.18 (95% CI −0.33 to −0.03)
I2 = 0%
1.4.5 LDL-C Exclude study biased on incomplete outcome
data (Feng 2006)
MD −0.38 (95% CI −0.72 to −0.04)
I2 = not applicable
1.14.1(TC-HDL-C)/HDL-C Exclude study biased on incomplete outcome
data (Li 2006)
MD 0.14 (95% CI −0.26 to 0.54)
I2 = not applicable